About GLP-1
GLP-1 (Glucagon-Like Peptide-1) is an incretin hormone peptide involved in glucose homeostasis and widely used in metabolic research. Supplied as a lyophilized powder for laboratory investigations into incretin signaling, insulin secretion pathway markers, and glucagon regulation mechanisms in controlled experimental models. Each batch undergoes analytical verification for identity and purity using HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: 99%+ (HPLC verified) Storage: Store desiccated at ?20�C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.
Latest Research
Brain Amylin Signaling, Feeding, and Reward.
Recent research on GLP-1: Brain Amylin Signaling, Feeding, and Reward.
Read Full Study on PubMedAssociation of glucagon-like peptide-1 receptor agonist use with clinical outcomes in patients with rheumatoid arthritis and type 2 diabetes.
Recent research on GLP-1: Association of glucagon-like peptide-1 receptor agonist use with clinical outcomes in patients with rheumatoid arthritis and type 2 diabetes.
Read Full Study on PubMedAdditional Studies
Implementation or Intrinsic Efficacy? Interpreting Real-World Comparisons of GLP-1 Receptor Agonists.
Recent research on GLP-1: Implementation or Intrinsic Efficacy? Interpreting Real-World Comparisons of GLP-1 Receptor Agonists.
Read on PubMedKidney Disease and Heart Failure: Recent Advances and Current Challenges: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Recent research on GLP-1: Kidney Disease and Heart Failure: Recent Advances and Current Challenges: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Read on PubMedSGLT2 inhibitors, GLP-1 RAs, and DPP4 inhibitors and the risk of hypomagnesemia in type 2 diabetes: A target trial emulation.
Recent research on GLP-1: SGLT2 inhibitors, GLP-1 RAs, and DPP4 inhibitors and the risk of hypomagnesemia in type 2 diabetes: A target trial emulation.
Read on PubMedROCK signaling at the crossroads of redox stress, mitochondrial dynamics, and metabolic disease.
Recent research on GLP-1: ROCK signaling at the crossroads of redox stress, mitochondrial dynamics, and metabolic disease.
Read on PubMedCapsaicin, allicin, and 6-gingerol: Modulation of gut microbiota and impact on metabolic, immune, and neurobiological health in mice.
Recent research on GLP-1: Capsaicin, allicin, and 6-gingerol: Modulation of gut microbiota and impact on metabolic, immune, and neurobiological health in mice.
Read on PubMedThe novel DPP-IV inhibitory peptides derived from goat milk: Purification, identification, bioactivities verification in-vitro and in-vivo.
Recent research on GLP-1: The novel DPP-IV inhibitory peptides derived from goat milk: Purification, identification, bioactivities verification in-vitro and in-vivo.
Read on PubMedRelated Research
Purchase GLP-1 from Verified Peptides
High-purity research peptides with full analytical verification
- 99% Purity (HPLC Verified)
- Full Certificate of Analysis
- Same Day Dispatch
- Free UK Shipping Over £75
Research Disclaimer
The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.